Annovis Bio, Inc. (ANVS)

CIK 1477845 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Annovis Bio, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 2026DEF 14A0001104659-26-107113
Aug 25, 2026PRE 14A0001104659-26-100460
Aug 14, 202610-Q0001104659-26-097228
Aug 14, 2026SCHEDULE 13G0000919574-26-005355
Aug 14, 20268-K0001104659-26-097091
Jul 29, 2026SCHEDULE 13G0000919574-26-004667
Jul 10, 20268-K0001104659-26-082341
Jun 17, 20268-K0001104659-26-075198
May 21, 202640001104659-26-065311
May 20, 2026424B50001104659-26-064510
May 20, 20268-K0001104659-26-064514
May 19, 2026424B50001104659-26-063959
May 15, 20268-K0001104659-26-062451
May 15, 202610-Q0001104659-26-062626
Apr 30, 2026DEFA14A0001104659-26-053130
Apr 30, 2026DEF 14A0001104659-26-053096
Apr 10, 20268-K0001104659-26-041584
Apr 9, 2026424B50001104659-26-041561
Apr 3, 202640001104659-26-039675
Apr 2, 20261440001972481-26-000128
Mar 25, 20268-K0001104659-26-034611
Mar 16, 20268-K0001104659-26-028574
Mar 13, 202610-K0001104659-26-027751
Feb 12, 20268-K0001104659-26-013948
Jan 28, 20268-K0001104659-26-007423